Polypodium leucotomos extract in atopic dermatitis: A randomized, double-blind, placebo-controlled, multicenter trial;Extracto de Polypodium leucotomos en dermatitis atópica: Ensayo multicéntrico, aleatorizado, doble ciego y controlado con placebo

Actas Dermo-Sifiliograficas

Volumn 103, Issue 7, 2012, Pages 599-607

  Ramirez Bosca A ^a   Zapater, P ^b   Betlloch, I ^b   Albero, F ^c   Martinez A ^a   Diaz Alperi J ^d   Horga, J F ^b  

^a Centro Dermatológico Estético de Alicante   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c HOSPITAL VIRGEN DE LOS LIRIOS   (Spain)

^d ASAC Pharma   (Spain)

Author keywords

Antihistamines; Atopic dermatitis; Polypodium leucotomos extract; Topical Corticosteroids

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; PLACEBO; POLYPODIUM LEUCOTOMOS EXTRACT;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG USE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 4 CLINICAL TRIAL; POLYPODIUM; POLYPODIUM LEUCOTOMOS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; INFANT; MALE; METHYLPREDNISOLONE; PHYTOTHERAPY; PLANT EXTRACTS; POLYPODIUM; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84864666333     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2012.01.008     Document Type: Article

References (25)

1. C. Ellis, T. Lugar The ICCAD II Faculty Internacional consensus conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies Br J Dermatol 148 Suppl 3 2003 3 10
2. A. Conde-Toboada, F.J. González Barcala, and J. Toribio Dermatitis atópica infantil: revisión y actualización Actas Dermosifilogr 99 2008 690 700
3. T. Bieber Atopic dermatitis N Engl J Med 358 2008 1483 1494
4. R.M. Levy, J.M. Gelfand, and A.C. Yan The Epidemiology of Atopic Dermatitis Clin Dermatol 21 2003 109 115 (Pubitemid 36428981)
5. J.C. Su, A.S. Kemp, G.A. Varigos, and T.M. Nolan Atopic eczema: its impact on the family and financial cost Arch Dis Child 76 1997 159 162 (Pubitemid 27086890)
6. National Institute for health and clinical excellence. Atopic eczema in children. Management of atopic eczema in children from birth up to the age of 12 years. NICE clinical guideline 57 [consultado Dec 2007]. Disponible en: http://www.nice.org.uk/nicemedia/pdf/CG057FullGuideline.pdf
7. M. Ridao Dermatitis atópica: clínica, diagnóstico diferencial y tratamiento Pediatr Integral 8 2004 204 210
8. F. Muñoz Dermatitis atópica en la edad infantil. Valoración de la gravedad y su tratamiento JANO 1432 2002 52 57
9. S. Schoepe, H. Schäcke, E. May, and K. Asadullah Glucocorticoid therapy-induced skin atrophy Exp Dermatol 15 2006 406 420
10. D.A. Fisher Adverse effects of topical corticosteroids use West J Med 162 1995 123 126
11. A.P. Castro Calcineurin inhibitors in the treatment of allergic dermatitis J Pediatr 82 S5 2006 166 172
12. J.M. Hanifin, and G. Rajka Diagnosis features of atopic dermatitis Acta Derm Venereol 92 1980 44 47
13. European Task Force on Atopic Dermatitis Severity scoring of atopic dermatitis: the SCORAD index Dermatology 186 1993 23 31
14. Beltran B, Martínez BP, Ruiz FJ. Nuevo tratamiento efectuado con 130 niños afectados de dermatitis atópica. XIII Congreso Nacional Sociedad Española de Alergia e Inmunología Clínica. Sevilla; 1983.
15. A. Ramírez-Boscá, A. Martínez, M. González, J. Gosálbez, and J. Ballester Reducción en el consumo de corticoides tópicos en pacientes con dermatitis atópica tratados con anapsos. Descripción de una serie de casos Doyma Update 2008
16. M. Meurer, R. Fölster-Holst, G. Wozel, G. Weidinger, M. Jünger, and M. Bräutigam CASM-DE-01 study group. Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study Dermatology 205 2002 271 277
17. M. Meurer, M. Fartasch, G. Albrecht, T. Vogt, M. Worm, T. Ruzicka CASM-DE-01 Study Group Long-term efficacy and safety of pimecrolimus cream 1% in adults with moderate atopic dermatitis Dermatology 208 2004 365 372 (Pubitemid 38736667)
18. ®, an antipsoriatic drug which increases the proportion of supresor cells in human peripheral blood Ann Immunol 134C 1983 393 400 (Pubitemid 13075949)
19. ® (Polypodium leucotomos extract) on in vitro production of cytokines Br J Clin Pharmacol 43 1997 85 89 (Pubitemid 27060275)
20. ® sobre la producción in vitro de citocinas en células mononucleares de sangre periférica humanas Natura Medicatrix 49 1998 38 40
21. ® (Polypodium leucotomos) modulates lymphoid cells and the expression of adhesion molecules Pharmacol Res 46 2002 185 190
22. ®) Br J Rheumatol 37 1998 912 (Pubitemid 28393763)
23. ®, una nueva orientación terapéutica en las manifestaciones digestivas del estado atópico Acta Ped Esp 46 1988 556 561
24. ® modifies immunological parameters and improves the clinical course in atopic dermatitis Dermatologica 173 1986 154 155
25. D. Jiménez, R. Naranjo, E. Doblare, C. Muñoz, and J.F. Vargas Anapsos, an antipsoriatic drug, in atopic dermatitis Allergol Immunopathol (Madr) 15 1987 185 189 (Pubitemid 18076339)